Analyst Price Target is $156.67
▲ +20.45% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for iRhythm Technologies in the last 3 months. The average price target is $156.67, with a high forecast of $185.00 and a low forecast of $116.00. The average price target represents a 20.45% upside from the last price of $130.07.
Current Consensus is
The current consensus among 10 polled investment analysts is to buy stock in iRhythm Technologies. This Buy consensus rating has held steady for over two years.
iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, continuously records, and stores ECG data from every patient heartbeat for up to 14 consecutive days; and Zio AT, also provides ECG data but also provides physicians with actionable notifications during the wear period. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.